BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34431499)

  • 1. Transforming growth factor β3 deficiency promotes defective lipid metabolism and fibrosis in murine kidney.
    Escasany E; Lanzón B; García-Carrasco A; Izquierdo-Lahuerta A; Torres L; Corrales P; Rodríguez Rodríguez AE; Luis-Lima S; Martínez Álvarez C; Javier Ruperez F; Ros M; Porrini E; Rydén M; Medina-Gómez G
    Dis Model Mech; 2021 Sep; 14(9):. PubMed ID: 34431499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGFβ2 and TGFβ3 isoforms drive fibrotic disease pathogenesis.
    Sun T; Huang Z; Liang WC; Yin J; Lin WY; Wu J; Vernes JM; Lutman J; Caplazi P; Jeet S; Wong T; Wong M; DePianto DJ; Morshead KB; Sun KH; Modrusan Z; Vander Heiden JA; Abbas AR; Zhang H; Xu M; N'Diaye EN; Roose-Girma M; Wolters PJ; Yadav R; Sukumaran S; Ghilardi N; Corpuz R; Emson C; Meng YG; Ramalingam TR; Lupardus P; Brightbill HD; Seshasayee D; Wu Y; Arron JR
    Sci Transl Med; 2021 Aug; 13(605):. PubMed ID: 34349032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fra-2 mediates oxygen-sensitive induction of transforming growth factor beta in cardiac fibroblasts.
    Roy S; Khanna S; Azad A; Schnitt R; He G; Weigert C; Ichijo H; Sen CK
    Cardiovasc Res; 2010 Sep; 87(4):647-55. PubMed ID: 20427335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGFbeta1 and TGFbeta3 are partially redundant effectors in brain vascular morphogenesis.
    Mu Z; Yang Z; Yu D; Zhao Z; Munger JS
    Mech Dev; 2008; 125(5-6):508-16. PubMed ID: 18343643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of transforming growth factor-β subtypes on in vitro cartilage production and mineralization of human bone marrow stromal-derived mesenchymal stem cells.
    Cals FL; Hellingman CA; Koevoet W; Baatenburg de Jong RJ; van Osch GJ
    J Tissue Eng Regen Med; 2012 Jan; 6(1):68-76. PubMed ID: 21305699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tgfb1 expressed in the Tgfb3 locus partially rescues the cleft palate phenotype of Tgfb3 null mutants.
    Yang LT; Kaartinen V
    Dev Biol; 2007 Dec; 312(1):384-95. PubMed ID: 17967447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor beta (TGFbeta1, TGFbeta2 and TGFbeta3) null-mutant phenotypes in embryonic gonadal development.
    Memon MA; Anway MD; Covert TR; Uzumcu M; Skinner MK
    Mol Cell Endocrinol; 2008 Nov; 294(1-2):70-80. PubMed ID: 18790002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression patterns of Tgfbeta1-3 associate with myocardialisation of the outflow tract and the development of the epicardium and the fibrous heart skeleton.
    Molin DG; Bartram U; Van der Heiden K; Van Iperen L; Speer CP; Hierck BP; Poelmann RE; Gittenberger-de-Groot AC
    Dev Dyn; 2003 Jul; 227(3):431-44. PubMed ID: 12815630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoform-specific effects of transforming growth factor β on endothelial-to-mesenchymal transition.
    Sabbineni H; Verma A; Somanath PR
    J Cell Physiol; 2018 Nov; 233(11):8418-8428. PubMed ID: 29856065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand-specific function of transforming growth factor beta in epithelial-mesenchymal transition in heart development.
    Azhar M; Runyan RB; Gard C; Sanford LP; Miller ML; Andringa A; Pawlowski S; Rajan S; Doetschman T
    Dev Dyn; 2009 Feb; 238(2):431-42. PubMed ID: 19161227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and action of transforming growth factor beta (TGFbeta1, TGFbeta2, TGFbeta3) in normal bovine ovarian surface epithelium and implications for human ovarian cancer.
    Nilsson E; Doraiswamy V; Parrott JA; Skinner MK
    Mol Cell Endocrinol; 2001 Sep; 182(2):145-55. PubMed ID: 11514049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of mice with a conditional allele for the transforming growth factor beta3 gene.
    Doetschman T; Georgieva T; Li H; Reed TD; Grisham C; Friel J; Estabrook MA; Gard C; Sanford LP; Azhar M
    Genesis; 2012 Jan; 50(1):59-66. PubMed ID: 22223248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative stress is responsible for maternal diabetes-impaired transforming growth factor beta signaling in the developing mouse heart.
    Wang F; Reece EA; Yang P
    Am J Obstet Gynecol; 2015 May; 212(5):650.e1-11. PubMed ID: 25595579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of transforming growth factor β induced cell cycle arrest in palate development.
    Iordanskaia T; Nawshad A
    J Cell Physiol; 2011 May; 226(5):1415-24. PubMed ID: 20945347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mice that lack activity of alphavbeta6- and alphavbeta8-integrins reproduce the abnormalities of Tgfb1- and Tgfb3-null mice.
    Aluwihare P; Mu Z; Zhao Z; Yu D; Weinreb PH; Horan GS; Violette SM; Munger JS
    J Cell Sci; 2009 Jan; 122(Pt 2):227-32. PubMed ID: 19118215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inorganic nitrate and nitrite ameliorate kidney fibrosis by restoring lipid metabolism via dual regulation of AMP-activated protein kinase and the AKT-PGC1α pathway.
    Li X; Zhuge Z; Carvalho LRRA; Braga VA; Lucena RB; Li S; Schiffer TA; Han H; Weitzberg E; Lundberg JO; Carlström M
    Redox Biol; 2022 May; 51():102266. PubMed ID: 35217293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGFbeta1, TGFbeta2, and TGFbeta3 protein expression in gastric carcinomas: correlation with prognostics factors and patient survival.
    Vagenas K; Spyropoulos C; Gavala V; Tsamandas AC
    J Surg Res; 2007 May; 139(2):182-8. PubMed ID: 17270215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P311 Promotes Lung Fibrosis via Stimulation of Transforming Growth Factor-β1, -β2, and -β3 Translation.
    Duan FF; Barron G; Meliton A; Mutlu GM; Dulin NO; Schuger L
    Am J Respir Cell Mol Biol; 2019 Feb; 60(2):221-231. PubMed ID: 30230348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrin alpha1beta1 and transforming growth factor-beta1 play distinct roles in alport glomerular pathogenesis and serve as dual targets for metabolic therapy.
    Cosgrove D; Rodgers K; Meehan D; Miller C; Bovard K; Gilroy A; Gardner H; Kotelianski V; Gotwals P; Amatucci A; Kalluri R
    Am J Pathol; 2000 Nov; 157(5):1649-59. PubMed ID: 11073824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-β3 (TGF-β3) knock-in ameliorates inflammation due to TGF-β1 deficiency while promoting glucose tolerance.
    Hall BE; Wankhade UD; Konkel JE; Cherukuri K; Nagineni CN; Flanders KC; Arany PR; Chen W; Rane SG; Kulkarni AB
    J Biol Chem; 2013 Nov; 288(44):32074-92. PubMed ID: 24056369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.